Related references
Note: Only part of the references are listed.Explorative Randomized Phase II Clinical Study of the Efficacy and Safety of Finafloxacin versus Ciprofloxacin for Treatment of Complicated Urinary Tract Infections
F. Wagenlehner et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Finafloxacin overcomes Burkholderia pseudomallei efflux-mediated fluoroquinolone resistance
Linnell B. Randall et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2017)
Pharmacodynamics of Finafloxacin, Ciprofloxacin, and Levofloxacin in Serum and Urine against TEM- and SHV-Type Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae Isolates from Patients with Urinary Tract Infections
A. Dalhoff et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
The Association of Age and Antibiotic Resistance of Helicobacter Pylori: A Study in Jiaxing City, Zhejiang Province, China
Zizhong Ji et al.
MEDICINE (2016)
Early response to antibiotic treatment in European patients hospitalized with complicated skin and soft tissue infections: analysis of the REACH study
Javier Garau et al.
BMC INFECTIOUS DISEASES (2015)
Urinary tract infections: epidemiology, mechanisms of infection and treatment options
Ana L. Flores-Mireles et al.
NATURE REVIEWS MICROBIOLOGY (2015)
Alternative Strategies for Proof-of-Principle Studies of Antibacterial Agents
Axel Dalhoff et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
EUCAST expert rules in antimicrobial susceptibility testing
R. Leclercq et al.
CLINICAL MICROBIOLOGY AND INFECTION (2013)
Comparison of pathogens and their antimicrobial resistance patterns in paediatric, adult and elderly patients in Canadian hospitals
Heather J. Adam et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2013)
Dosing Regimen Matters: the Importance of Early Intervention and Rapid Attainment of the Pharmacokinetic/Pharmacodynamic Target
Marilyn N. Martinez et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Progress on Developing Endpoints for Registrational Clinical Trials of Community-Acquired Bacterial Pneumonia and Acute Bacterial Skin and Skin Structure Infections: Update From the Biomarkers Consortium of the Foundation for the National Institutes of Health
George H. Talbot et al.
CLINICAL INFECTIOUS DISEASES (2012)
Resistance surveillance studies: a multifaceted problem-the fluoroquinolone example
A. Dalhoff
INFECTION (2012)
Daptomycin: A Review of Properties, Clinical Use, Drug Delivery and Resistance
C. Vilhena et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2012)
In Vitro Spectrum of Activity of Finafloxacin, a Novel, pH-Activated Fluoroquinolone, under Standard and Acidic Conditions
Will Stubbings et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Activity of finafloxacin, a novel fluoroquinolone with increased activity at acid pH, towards extracellular and intracellular Staphylococcus aureus, Listeria monocytogenes and Legionella pneumophila
Sandrine Lemaire et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2011)
Comparative in vitro activity of finafloxacin against staphylococci displaying normal and small colony variant phenotypes
Evgeny A. Idelevich et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2011)
Bactericidal activity of daptomycin versus vancomycin in the presence of human albumin against vancomycin-susceptible but tolerant methicillin-resistant Staphylococcus aureus (MRSA) with daptomycin minimum inhibitory concentrations of 1-2 μg/mL
M. Torrico et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2010)
Antibacterial activity of finafloxacin under different pH conditions against isogenic strains of Escherichia coli expressing combinations of defined mechanisms of fluoroquinolone resistance
Nadine-C. Emrich et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
Impact of Low-Level Resistance to Fluoroquinolones Due to qnrA1 and qnrS1 Genes or a gyrA Mutation on Ciprofloxacin Bactericidal Activity in a Murine Model of Escherichia coli Urinary Tract Infection
Nicolas Allou et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
A cost-effectiveness analysis of antimicrobial treatment of community-acquired pneumonia taking into account resistance in Belgium
Monique Martin et al.
CURRENT MEDICAL RESEARCH AND OPINION (2008)
Daptomycin versus vancomycin for complicated skin and skin structure infections: Clinical and economic outcomes
Susan L. Davis et al.
PHARMACOTHERAPY (2007)
Comparative bactericidal activities of daptomycin and vancomycin against glycopeptide-intermediate Staphylococcus aureus (GISA) and heterogeneous GISA isolates
Mandy Wootton et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
An economic evaluation of sequential IV/po moxifloxacin therapy compared to IV/po co-amoxidav with or without clarithromycin in the treatment of community-acquired pneumonia
MF Drummond et al.
CHEST (2003)
Antimicrobial resistance among uropathogens that cause community-acquired urinary tract infections in women: A nationwide analysis
K Gupta et al.
CLINICAL INFECTIOUS DISEASES (2001)
Share Paper
